Related Experiment Videos
Do published criteria improve clinical diagnostic accuracy in multiple system atrophy?
Y Osaki1, G K Wenning, S E Daniel
1National Hospital for Neurology and Nuerosurgery, London, UK.
Objective:
To assess the accuracy of a clinical diagnosis of multiple system atrophy (MSA) and compare it to the Quinn and Consensus criteria for MSA using neuropathologically examined cases from the Queen Square Brain Bank for Neurological Disorders.
Methods:
Fifty-nine cases with a neurologic diagnosis of MSA when last assessed prior to death were studied.
Results:
In 51 (86%) of these cases, the diagnosis of MSA was confirmed pathologically. False positive diagnoses included PD (n = 6), progressive supranuclear palsy (n = 1), and cerebrovascular disease (n = 1). When applying either set of diagnostic criteria, a diagnosis of probable MSA gave lower sensitivity but higher positive predictive value than one of possible MSA. Application of either set of diagnostic criteria was superior to actual clinical diagnosis made early in the disease, but there was little difference by the last clinic visit.
Conclusions:
This study shows a high diagnostic accuracy for the clinical diagnosis of MSA by neurologists, with PD accounting for most of the false positive diagnoses. Application of either Quinn or Consensus criteria was superior to actual clinical diagnosis made early in the disease, but there was little difference by last clinic visit.
Insights
Neurologists accurately diagnose multiple system atrophy (MSA) in most cases, though Parkinson's disease (PD) is a common misdiagnosis. Diagnostic criteria improve early detection compared to clinical judgment alone.
Area of Science:
- Neurology
- Neuroscience
- Pathology
Background:
- Multiple system atrophy (MSA) is a rare neurodegenerative disorder.
- Accurate early diagnosis of MSA is challenging but crucial for patient management.
Purpose of the Study:
- To evaluate the accuracy of clinical MSA diagnosis.
- To compare clinical diagnosis with established criteria (Quinn and Consensus) using neuropathological data.
Main Methods:
- Analysis of 59 neuropathologically examined cases with a prior clinical diagnosis of MSA.
- Comparison of clinical diagnosis and diagnostic criteria (Quinn, Consensus) against pathological confirmation.
Main Results:
- Pathological confirmation of MSA in 86% of clinically diagnosed cases.
- Parkinson's disease (PD) was the most frequent false positive diagnosis (n=6).
- Diagnostic criteria showed higher positive predictive value but lower sensitivity than clinical diagnosis, especially early in the disease.
Conclusions:
- Clinical diagnosis of MSA by neurologists demonstrates high accuracy.
- Established diagnostic criteria (Quinn, Consensus) are superior to early clinical diagnosis but show minimal difference by the last clinic visit.